HEALTH CARE DEVICE AND HEALTH CARE METHOD

Abstract

A health care device and a health care method are illustrated, the health care method is used to arrange the health care device at a predetermined location in front of a belly button of a user with a predetermined distance, and to emit the low-frequency wave with a predetermined frequency to the belly button by using a low-frequency wave emitter. The health care device is formed by the low-frequency wave emitter and a cone/pyramid part. The predetermined frequency is 1.27 Hz to 1.81 Hz, and the predetermined distance is 5 cm to 8 cm. The above health care device and method can increase contents of active T cells and B cells in blood and increase an ability of NK cell strains for poisoning cancer cell strains (K562). In short, the above health care device and method have health benefits without a risk of excessive energy causing harm.

Claims

1. A health care device, at least comprising: a cone/pyramid part, having a vertex, a bottom surface and a body, wherein two ends of the body of the cone/pyramid part are respectively connected to the vertex and the bottom surface of the cone/pyramid part; and a low-frequency wave emitter, connected to the bottom surface of the cone/pyramid part, configured to emit a low-frequency wave with a predetermined frequency.

2. The health care device of claim 1, wherein the predetermined frequency is 1.27 Hz to 1.81 Hz.

3. The health care device of claim 2, wherein the predetermined frequency is 1.45 Hz.

4. The health care device of claim 3, wherein the low-frequency wave emitter is an infrasonic transducer, and the low-frequency wave is an infrasonic wave.

5. The health care device of claim 4, wherein the cone/pyramid part is a one-piece wooden cone or pyramid.

6. A health care device, arranged at a predetermined location in front of a belly button of a user with a predetermined distance, comprising at least a low-frequency wave emitter.

7. A health care method, comprising: arranging the health care device of claim 1 at a predetermined location in front of a belly button of a user with a predetermined distance; and using the health care device to emit the low-frequency wave with a predetermined frequency to the belly button.

8. The health care method of claim 7, wherein the predetermined frequency is 1.27 Hz to 1.81 Hz.

9. The health care method of claim 8, wherein the predetermined frequency is 1.45 Hz.

10. The health care method of claim 8, wherein the low-frequency wave emitter is an infrasonic transducer, and the low-frequency wave is an infrasonic wave.

11. The health care method of claim 9, wherein the cone/pyramid part is a one-piece wooden cone or pyramid.

12. The health care method of claim 10, wherein the predetermined location is located on a virtual bottom surface of a virtual cone/pyramid above the belly button, the predetermined distance is 5 cm to 8 cm; the predetermined location is located on a center of the virtual bottom surface, the virtual cone/pyramid is a virtual cone, the predetermined location is a circular center of the virtual bottom surface, the predetermined distance is a distance from the circular center of the virtual bottom surface to the belly button, and the vertex is located on the predetermined location.

Description

BRIEF DESCRIPTIONS OF DRAWINGS

[0025] The accompanying drawings are included to provide a further understanding of the present disclosure and are incorporated in and constitute a part of this specification. The drawings illustrate exemplary embodiments of the present disclosure and, together with the description, which are used to explain the principles of the present disclosure.

[0026] FIG. 1 is a schematic diagram of executing a health care method according to an embodiment of the present disclosure.

[0027] FIG. 2 is a schematic diagram showing a structure of a health care device when executing a health care method according to an embodiment of the present disclosure.

[0028] FIG. 3 is a schematic diagram showing a structure of a health care device according to an embodiment of the present disclosure.

[0029] FIG. 4 is a schematic diagram showing a structure of a health care device with a tube according to an embodiment of the present disclosure.

[0030] FIG. 5 is a schematic diagram showing a structure of a health care device with a vertically standing rod according to an embodiment of the present disclosure.

[0031] FIG. 6 is a schematic diagram showing a structure of a health care device installed on or in a frame according to an embodiment of the present disclosure.

[0032] FIG. 7 is a schematic diagram showing a structure that a low-frequency wave emitter of a health care device is installed on a bottom surface of a cone/pyramid part according to an embodiment of the present disclosure.

DETAILS OF EMBODIMENTS

[0033] To understand the technical features, content and advantages of the present disclosure and its efficacy, the present disclosure will be described in detail with reference to the accompanying drawings. The drawings are for illustrative and auxiliary purposes only and may not necessarily be the true scale and precise configuration of the present disclosure. Therefore, the scope of the present disclosure should not be limited to the scale and configuration of the attached drawings.

[0034] Refer to FIG. 1, the present disclosure provides a health care method. The method arranges a low-frequency wave emitter 2 at a predetermined location P in front of a belly button 11 of a user 1 with a predetermined distance D and makes the low-frequency wave emitter 2 emit a low-frequency wave W of the predetermined frequency forward to the belly button 11 of the user 1. The aforementioned front refers to the front of the body in the direction of the abdomen, and correspondingly, the back refers to the back of the human body. The predetermined location P is located on a virtual bottom surface S2 of a virtual cone/pyramid S with the belly button 11 as a virtual vertex S1 of the virtual cone/pyramid S. The predetermined distance D is designed to be not larger than 8 cm, or the predetermined distance D is designed to be not less than 5 cm, or the predetermined distance D is designed to be within a range between 5 cm and 8 cm (p.s. the range comprises two end values of 5 cm and 8 cm). Preferably, the predetermined location P is located on the center of the virtual bottom surface S2, for example, the virtual cone/pyramid S is a cone, the predetermined location P is located on the circular center of the virtual bottom surface S2 being a circle surface, and the predetermined distance D is the distance between circular center and the belly button 11, which is within the range between 5 cm and 8 cm.

[0035] The low-frequency wave emitter 2 is preferably an infrasonic transducer, and the low-frequency wave W can be the infrasonic. The structure of the infrasonic transducer comprises a power supply 21 and a vibration part 22. The vibration part 22 is electrically connected to the power supply 21. The vibration part 22 is a disc-shaped piezoelectric ceramic transducer. The piezoelectric ceramic transducer is made of piezoelectric material polarized in the thickness direction. The power supply 21 provides power to the vibration part 22 to make the vibration part 22 vibrates in the thickness direction to generate the infrasonic of the predetermined frequency. In the present disclosure, the predetermined frequency is not larger than 1.81 Hz, or the predetermined frequency is not less than 1.27 Hz, or the predetermined frequency is within a range between 1.27 Hz and 1.81 Hz (p.s. the range comprises two end values of 1.27 Hz and 1.8 Hz). Preferably, the predetermined frequency is 1.45 Hz.

[0036] In other words, the present disclosure also provides a health care device, the health care device is arranged at a predetermined location P in front of the belly button 11 of the user with a predetermined distance D. The health care device at least comprises a low-frequency wave emitter 2.

[0037] <Detection Manner and Effect of Experiment 1>

[0038] The health care method is executed to personnel A1 and personnel A2, the predetermined distance D is selected to be 5 cm, the predetermined frequency is selected to be 1.45 Hz, and the low-frequency wave is selected to be the infrasonic. The personnel A1 is a 74-years old man, the personnel A2 is a 72-years old woman. Before executing the health care method, blood samples are drawn from the personnel A1 and personnel A2 and sent to the medical laboratory for immunological examination to check the percentage (i.e., content) of the active T cells. On the 19-th day after the execution of the health care method for 2 hours, the blood sample of the personnel A1 is again taken and sent to the medical laboratory for immunological examination, and on the 42-nd day after the execution of the health care method for 2 hours, the blood sample of the personnel A2 is also taken again and sent to the medical laboratory for immunological examination. The percentages of the active T cells of the blood samples are examined in the same way, and the results are recorded in TABLE 1 which is described later.

TABLE-US-00001 TABLE 1 PERSONNEL A1 PERSONNEL A2 CHANGE CHANGE RATE = RATE = CONTENT CONTENT OF ACTIVE OF ACTIVE T CELLS T CELLS AFTER AFTER EXECUTION/ EXECUTION/ CONTENT CONTENT OF ACTIVE OF ACTIVE T CELLS T CELLS BEFORE AFTER BEFORE BEFORE AFTER BEFORE EXECUTION EXECUTION EXECUTION EXECUTION EXECUTION EXECUTION CONTENT 6.2% 12.8% 206.5% 5.3% 7.9% 149% OF ACTIVE T CELLS

[0039] From TABLE 1, before executing the health care method, the content of the active T cells in personnel A1 is 6.2%, and after executing the health care method, the content of the active T cells increases to 12.8%, and the change rate is 206.5%, that is, the content increment of the active T cells is 106.5%. Before executing the health care method, the content of the active T cells in personnel A2 is 5.3%, and after executing the health care method, the content of the active T cells is increased to 7.9%, and the change rate is 149%, that is, the content increment of the active T cells is 49%. Therefore, the health care method provided by the present disclosure can promote the proliferation of the active T cells, and if a single execution of 2 hours can make the content of the active T cells increase, even after 42 days, the content increment of the active T cells can still maintain to be 49%. Apparently, the health care method of the present disclosure is highly effective and can maintain long-term health effects.

[0040] <Detection Manner and Effect of Experiment 2>

[0041] The health care method is executed to 14 people, the predetermined distance D is selected to be 5 cm, the predetermined frequency is selected to be 1.45 Hz, and the low-frequency wave is selected to be the infrasonic. Before executing the health care method, blood samples are drawn from the 14 people and sent to the medical laboratory for immunological examination to check the percentage (i.e., content) of the B cells (CD19+). On the 19-th day after the execution of the health care method for 2 hours, the blood samples of the 14 people are again taken and sent to the medical laboratory for immunological examination, the percentages of the B cells of the blood samples are examined in the same way, and the results are recorded in TABLE 2 which is described later.

TABLE-US-00002 TABLE 2 CHANGE RATE = CONTENT OF B CELLS AFTER EXECUTION/ CONTENT OF B BEFORE AFTER CELLS BEFORE EXECUTION EXECUTION EXECUTION CONTENT 12.2% 13.6% 111.4% OF B CELLS

[0042] From TABLE 2, before executing the health care method, the average content of the B cells in the 14 people is 12.2%, and after executing the health care method, the average content of the B cells in the 14 people is increased to 13.6%, and the change rate is 111.4%, that is, the average content increment of the active T cells of the B cells is 11.4%. Therefore, the health care method provided by the present disclosure can promote the proliferation of the B cells, and if a single execution of 2 hours can make the content of the B cells increase. Apparently, the health care method of the present disclosure is highly effective for health.

[0043] <Detection Manner and Effect of Experiment 3>

[0044] The health care method is executed to personnel B1 and personnel B2, the predetermined distance D is selected to be 5 cm, the predetermined frequency is selected to be 1.45 Hz, and the low-frequency wave is selected to be the infrasonic. Before executing the health care method, blood samples are drawn from the personnel B1 and personnel B2 and sent to the medical laboratory for immunological examination. On the 19-th day after the execution of the health care method for 2 hours, the blood sample of the personnel B1 and personnel B2 are again taken and sent to the medical laboratory for immunological examination. Regarding each of the blood samples before the execution of the health care method and after the execution of the health care method, the NK cells and the cancer cell strains (K562) of the blood are mixed with a ratio of 6.25:1 (effector:target) to co-cultivate, and then the death status of the cancer cell strains is analyzed, thus obtaining the ability (the unit is percentage) of the NK cell for poisoning the cancer cell strains (the relative operation details for measuring the ability of the NK cell for poisoning the cancer cell strains can be further seen in TW patent I439275). The data of the abilities of the NK cell for poisoning the cancer cell strains is recorded in TABLE 3.

TABLE-US-00003 TABLE 3 PERSONNEL B1 PERSONNEL B2 CHANGE CHANGE RATE = RATE = ABILITY ABILITY AFTER AFTER EXECUTION/ EXECUTION/ ABILITY ABILITY BEFORE AFTER BEFORE BEFORE AFTER BEFORE EXECUTION EXECUTION EXECUTION EXECUTION EXECUTION EXECUTION Percentage 24.3% 33.6% 138.3% 5.5% 7.2% 131% of cancer cell strains which is poisoned and killed by the NK cells

[0045] From TABLE 3, before executing the health care method, the ability of the NK cell strains for poisoning the cancer cell strains (K562) of the personnel B1 is 24.3%, and after executing the health care method, the ability of the NK cell strains for poisoning the cancer cell strains (K562) of the personnel B1 is increased to 33.6%, and the change rate is 138.3%, that is, the poisoning ability increment is 38.3%. Before executing the health care method, the ability of the NK cell strains for poisoning the cancer cell strains (K562) of the personnel B2 is 5.5%, and after executing the health care method, the ability of the NK cell strains for poisoning the cancer cell strains (K562) of the personnel B2 is increased to 7.2%, and the change rate is 131%, that is, the poisoning ability increment is 31%. Therefore, the health care method provided by the present disclosure can promote ability of the NK cell strains for poisoning the cancer cell strains (K562). Apparently, the health care method of the present disclosure is highly effective and can maintain long-term health effects.

[0046] Refer to FIG. 2 and FIG. 3, the present disclosure further provides a health care device 100 for executing the above health care method. The health care device 100 comprises the low-frequency wave emitter 2, a column part 3 and a cone/pyramid part 4. The column part 3 is preferably the circular column, the column part 3 has a top surface 31, a bottom surface 32 and a body 33, and the two ends of the body 33 of the column part 3 are respectively connected to the top surface 31 of column part 3 and the bottom surface 32 of column part 3. The cone/pyramid part 4 has a vertex 40, a bottom surface 41 and a body 42, wherein two ends of the body 42 of the cone/pyramid part 4 are respectively connected to the vertex 40 and the bottom surface 41 of the cone/pyramid part 4. The top surface 31 of the column part 3 is correspondingly joined with the bottom surface 41 of the cone/pyramid part 4, for example, by welding or screwing. Preferably, the column part 3 and the cone/pyramid part 4 are respectively metal columns and metal cones, respectively. More preferably, the column part 3 and the cone/pyramid part 4 are formed integrally, in other words, the top surface 31 of the column part 3, the body 33 of the column part 3, the body 42 of the cone/pyramid part 4 and the vertex 40 of the cone/pyramid part 4 are formed integrally, i.e., the column part 3 and the cone/pyramid part 4 are one-piece part.

[0047] The low-frequency wave emitter 2 is connected with the bottom surface 32 of the column part 3, preferably this low-frequency wave emitter 2 is directly connected with the bottom surface 32 of the column part 3, such as this low-frequency wave emitter 2 is welded or screwed to the bottom surface 32 of the column part 3, so when the power supply 21 is activated, the vibration part 22 will generate the low-frequency wave W of the predetermined frequency (please refer to FIG. 1 again). Next, the low-frequency wave W is transmitted to this bottom surface 32 of column part 3, and the body 33 of the column part 3 is used to transmit the low-frequency wave W sequentially to the bottom surface 41 of the cone/pyramid part 4 and this vertex 40. By using the structure of the cone/pyramid part 4 which the bottom surface 41 of the cone/pyramid part 4 is designed to be wider than and tapered to the vertex 40, the energy of the low-frequency wave W is more concentrated as it is transmitted towards the vertex 40. Therefore, when the low-frequency wave W is delivered to this vertex 40, the energy of the low-frequency wave W is gathered to the maximum, and then emitted towards the belly button 11 from the vertex 40. The vertex 40 of the cone/pyramid part 4 is a tip, and therefore, based on the principle of the tip discharge in electricity, the low-frequency wave W can be concentrated on the vertex 40 to be released and emitted towards the belly button 11. It is noted that, the vertex 40 is located at the predetermined location P at this time.

[0048] Refer to FIG. 4, and in another one embodiment, the low-frequency wave emitter 2 is connected to the bottom surface 32 of column part 3 via a tube 5. The low-frequency wave W is transmitted to the bottom surface 32 of the column part 3 via the tube 5. The low-frequency wave W then passes to the vertex 40 and is emitted towards the belly button 11 as previously described. With the arrangement of the tube 5, the power supply 21 and/or the vibration part 22 of the low-frequency wave emitter 2 can be kept away from the human body, to avoid interference with any electronic device which has implanted in the human body.

[0049] Refer to FIG. 5, and in another one embodiment, the vertex 40 further has a rod 401 being vertically standing and having a longitudinal direction away from the bottom surface 41 of the cone 4. Preferably, the rod 401 is a metal rod such as metal silk or metal wire. The longitudinal direction of the rod 401 is coincided with a normal line N of the center C on the bottom surface 41 of the cone/pyramid part 4, and the normal line N of the center C on the bottom surface 41 of the cone/pyramid part 4 passes extends towards the belly button 11. Therefore, the energy of the low-frequency wave W can be more directed to concentrate on a tip 402 of the rod 401 to be released and emitted towards the belly button 11. Specifically, the tip 402 is located at the predetermined location P at this time.

[0050] Refer to FIG. 6, in another one embodiment, the health care device 100 is installed in or on a frame 200, the user 1 is lying on the platform (not shown in the drawings), the frame 200 is erected on the platform, and the health care device 100 is located above the belly button of the user 1. In this way, the user 1 can also get a proper rest during the health care process.

[0051] Refer to FIG. 7, in another one embodiment, the health care device 100 can also comprises the low-frequency wave emitter 2 and the cone/pyramid part 4, but the column part 3 is not included in the health care device 100. The low-frequency wave emitter 2 is arranged on the bottom surface 41 of cone/pyramid part 4, and the low-frequency wave emitter 2 is connected to the bottom surface 41 of the cone/pyramid part 4. Preferably, the low-frequency wave emitter 2 is directly connected to the bottom surface 41 of cone/pyramid part, for example, the low-frequency wave emitter 2 is adhered, welded or screwed to the bottom surface 41 of the cone/pyramid part 4. Thus, after activating the power supply 21, the vibration part 22 vibrates to generate low-frequency wave W of the predetermined frequency (see FIG. 1 again). Next, the low-frequency wave W is transmitted to the bottom surface 41 of the cone/pyramid part 4 and vertex 40 of the cone/pyramid part 4. By using the cone/pyramid design that the diameter is tapered from the bottom surface 41 to the vertex 40 of the cone/pyramid part 4, the energy of the low-frequency wave W is getting concentrated when transmitting to the vertex 40. The cone/pyramid part 4 can be a wooden or metal cone or pyramid, and preferably, the cone/pyramid part 4 is a one-piece wooden cone or pyramid.

[0052] The above-mentioned descriptions represent merely the exemplary embodiment of the present disclosure, without any intention to limit the scope of the present disclosure thereto. Various equivalent changes, alternations or modifications based on the claims of present disclosure are all consequently viewed as being embraced by the scope of the present disclosure.